October 21, 2020

Make the Deal, Sweeten the Deal: The Appeal of Injunctive Relief Remedies in Class-Wide Settlements

Subscribe to Our Newsletter

Newsletter


Dean Gresham

|

October 21, 2020

The modern class action, now on the books for over fifty years, allows injunctive remedies under all three subsections of Rule 23(b). Injunctive remedies, requiring that a defendant alter one or more aspects of its business practices or offer claimants non-monetary compensation in exchange for the release of their claims, have become a regular feature in class action settlements.

Injunctive relief provisions, usually in combination with monetary damages, are attractive for a number of reasons. Retrospective injunctive relief is widely accepted across the class action litigation spectrum because it aims to remediate past known harms. Such relief could come in the form of repairs or recalls, changes in product design, manufacturing, warnings, labeling, or compliance-related obligations.

For classes comprised of repeat buyers of a product or service, prospective injunctive relief prevents the same harm from reoccurrence. Though incidental to the primary goals of class actions, such relief affects policy changes that can justify attorneys’ fees especially where monetary damages are small or nonexistent.

Injunctive Relief in Practice

Four recent decisions granting final approval of class-wide settlements illustrate the varying role injunctive relief plays in class action resolution. Whether the court: (1) found that injunctive measures were the only way to protect plaintiffs’ future interests ( see In Re: Equifax Inc. Customer Data Security Breach Litigation ); (2) found that unquantifiable injunctive relief was an adequate way to rectify class member injury ( see Clapp et. al., v. Accordia Life and Annuity Co. and Alliance-One Services, Inc. ); (3) recognized that injunctive relief was satisfactory as stand-alone relief ( see Littlejohn et. al., v. Ferrara Candy Company ); or (4) acknowledged that it comprised only a small component of a much larger settlement ( see In Re: GSE Bonds Antitrust Litigation ), injunctive remedies make or sweeten the deal for reviewing courts. Ideally for litigants, and as exemplified in the following cases, this means a total release of claims coupled with approval of attorneys’ fees.

In Re: Equifax Inc. Customer Data Security Breach Litigation , 1:17-md-2800, Dkt. No. 956 (N.D. Ga. January 13, 2020)

In September 2017, an estimated 147 million U.S. consumers had their personal information compromised in a cyberattack and data breach on Equifax, Inc. Consumers filed thousands of complaints that were consolidated before Judge Thomas W. Thrash Jr. of the United States District Court for the Northern District of Georgia. The parties agreed to a settlement in consultation with state and federal regulators in 2019.

Judge Thrash granted final approval of the settlement that allocated a minimum of $380 million into a common fund as the class benefit, $77.5 million of which was dedicated to attorneys’ fees. Equifax also agreed to pay up to $2 billion more for class member-elected credit monitoring and identity restoration services.

In terms of injunctive relief, the company agreed to comply with comprehensive data security requirements, to spend at least $1 billion on related technology over the next five years, and to subject itself to monitoring by a qualified third-party assessor. The court found that the $1 billion expenditure “benefits the class because it ensures adequate funding for securing plaintiffs’ information long after the case is resolved.”

Clapp et. al., v. Accordia Life and Annuity Co. and Alliance-One Services, Inc. , 2:17-cv-02097, Dkt. No. 66 (C.D. Ill. June 23, 2020)

Purchasers of consumer life insurance policies filed suit against two insurance companies in pursuit of damages and injunctive relief after the companies’ migration to a new electronic administration system caused their policies to freeze and lapse during a host of “Conversion-Related Issues.” On June 23, 2020, the Illinois federal court granted final approval of the parties’ settlement and awarded $2.2 million as attorneys’ fees.

The settlement incorporated both monetary and non-pecuniary remedies for the nearly 500,000 class members. The injunctive relief included a 24-month grace period to repay missed premiums, back-dating of premium payments to enable policyholders to receive retroactive fixed interest, and automatic corrections of forfeiture or negative tax implication statuses.

The defendants also agreed to review their own records to ensure class member notification, dedicate 75 specially-trained employees to help claimants navigate the settlement and resolve policy issues, and conduct “independent policy testing,” a plan overseen by a third-party accountant to ensure adequate redress of customer issues.

Noting that the value of the settlement differs for each class member, and may be limited to injunctive relief for some, the court considered, “[w]hat is that relief worth? Peace of mind, $5, $10, or $20?” In concluding that though unquantifiable, the measures were “valuable, adequate, and fair,” the court wrote “[i]t is sensible that each class member will receive injunctive relief tailored to the type of Conversion-Related Issues they experienced, such as lapsed policies, lost benefits, etc. The settlement requires that relief to be provided.”

Littlejohn et. al., v. Ferrara Candy Company , 3:18-cv-00658, Dkt. No. 47 (S.D. Cal. June 17, 2019), affirmed 19-55805, Dkt. No. 40-1 (9th Cir. June 30, 2020)

In a recent food-labeling class action, defendant Ferrara Candy Company agreed to pay $272,000 in attorney’s fees, and remove its “no artificial flavors” label from its SweeTARTS candy following allegations that the product contained an artificial additive. The settlement provided no monetary compensation for the class. Instead, it afforded them the opportunity to “make a learned judgment” regarding whether to purchase the candy again in the future.

A single objector appealed. In an unpublished opinion, the appellate court rejected the objector’s merits arguments. The panel confirmed that the district court independently analyzed and corroborated the propriety of the attorneys’ fees award, acknowledged the lack of significant economic injury to class members, weighed the risk plaintiffs ran in taking the case to trial, and recognized the value of the injunctive relief to class members, some of whom were repeat purchasers.

In Re: GSE Bonds Antitrust Litigation , 1:19-cv-01704, Dkt. No. 430 (S.D.N.Y. June 16, 2020)

Institutional and individual investor plaintiffs brought a class action alleging an overarching conspiracy to fix prices of Government-Sponsored Enterprises (“GSE”) bonds, inflating the price of those purchased in the secondary market by members of the putative class. Defendants were sixteen major domestic and foreign banks engaged in GSE bond trading. In its June 16, 2020 order, the court for the Southern District of New York approved settlements with the thirteen remaining defendants, as well as $77.5 million in attorneys’ fees, resolving all claims in the dispute.

Though the bulk of the value of the $337 million settlement was cash, the settlement provided for non-monetary relief in the form of antitrust compliance and monitoring. This was particularly important, because, as the plaintiffs noted, class members “are limited to dealing in high-credit government securities due to statutory or other constraints, [and] need to have confidence that the GSE Bond market is free from collusion.” In turn, the defendants agreed to maintain a compliance program, and for 24 months confer with plaintiffs to consider and evaluate antitrust compliance best practices in the GSE bond market.

In a preliminary approval order, the court acknowledged that the “substantial antitrust compliance remediation measures… provide[] some additional value.” In its final approval order, the court granted a $300,000 service award to the class representative, the Pennsylvania Treasury, in part because of its role in overseeing future injunctive relief measures. The court wrote that the award was warranted because the Pennsylvania Treasury will “continue to be involved in supervising compliance measures that it helped to develop to ensure the continued integrity of the GSE bond markets.”

Conclusion

Regardless of industry or cause of action, injunctive relief has a solid place in class action settlements. Although determining its precise value can be difficult, the court in Accordia Life and Annuity Co. acknowledged that injunctive relief has context-dependent value, whether looking forward to prevent future harm, or backwards to remediate past harms. Accordingly, practitioners should consider structuring deals with non-monetary injunctive relief as a primary or secondary remedy in order to pass muster with the court, win approval of attorneys’ fees, and obtain a release of claims.

Certum Group Can Help

Get in touch to start discussing options.

Recent Content

By Certum Team June 12, 2026
Certum Group is pleased to announce that Derrick Carman has joined the company as Legal Director responsible for underwriting and advising on patent litigation funding and acquisition opportunities. Mr. Carman will focus on patent underwriting and work alongside Chris Seidl to expand Certum’s intellectual property finance platform, which is Chambers & Partners ranked and includes patent litigation funding, acquisitions, and licensing opportunities. Mr. Carman joins Certum from Robins Kaplan LLP, where he was a Partner in the firm’s IP Litigation group and spent nearly a decade representing patent owners and defendants in high-stakes litigation before the U.S. Federal Courts, the International Trade Commission, and the U.S. Patent and Trademark Office. His matters have spanned a broad range of technologies, including software, computer memory systems, LTE/3G, batteries, chemical compositions, genetically modified cell lines, medical devices, projector systems, and laser technology. A registered patent attorney, Mr. Carman began his career at IBM drafting patent applications across software and hardware disciplines before joining Dorsey & Whitney LLP, where his practice spanned patent preparation, prosecution, and litigation. He earned his J.D., cum laude, from Syracuse University College of Law, where he served as Computer Editor of the Syracuse Law Review, and holds a B.S. in Physics from Denison University. He was recognized as a Best Lawyers in America “One to Watch” honoree and a Super Lawyers New York Rising Star. “Derrick brings a rare combination of technical depth, USPTO experience, and trial-tested litigation judgment,” said Joel Fineberg, Certum’s founder and managing director. “As we continue to grow our IP finance practice, having an underwriter who can evaluate patents at both the claim-construction level and the courtroom level is invaluable. We’re thrilled to welcome him to the team.” “I worked with Derrick for years in private practice, and there are few patent litigators I trust more to diligence a case from the ground up,” said Chris Seidl, Director and head of Certum’s IP finance strategies. “His technical training, prosecution background, and litigation experience give him a perspective on patent value that very few underwriters have. He’s going to be a tremendous addition to our IP team.” “I’ve spent my career working on the litigation side of patent disputes, and joining Certum is a natural next step — applying that same diligence and technical analysis to evaluating litigation as an investment,” said Mr. Carman. “Certum has built one of the most thoughtful platforms in the industry, and I’m looking forward to working with Chris and the rest of the Certum team to help patent holders and their counsel unlock the value of their assets.” See Derrick's announcement on Bloomberg Law , and learn more about his role at Certum Group HERE .
By Certum Team June 9, 2026
Trade secrets have quietly become the most commercially valuable intellectual property most growth-stage companies own — and the most contested. Federal trade secret filings hit an all-time high in 2025, and when these cases reach a verdict, plaintiffs win roughly 84% of the time. Yet the companies that hold these claims are too often making the most important decisions — which firm to hire, on what fee terms, whether to move for an injunction, how much to invest in forensics — in a matter of days, without a clear view of what their case is worth or how a sophisticated investor would underwrite it. To help business owners, executives, and in-house teams change that, Certum has released The Trade Secret Litigation Playbook — a comprehensive, plain-English guide to protecting trade secrets and recovering their value when someone takes them. This publication is now available for free download . Why We Wrote This Playbook : Most trade secret guides are written by lawyers, for lawyers. The Playbook is different. It is written for the people whose businesses depend on these assets and who have to make the early calls — often before counsel is even engaged. That moment matters. Across the matters Certum sees every week, the same patterns recur: Misappropriation discovered, but no preservation protocol issued in the first 72 hours Counsel hired on a structure that looks reasonable at signing but constrains the matter for years Damages framed around lost profits alone, leaving the largest measures of recovery unexamined Litigation finance considered as a last resort instead of a strategic option at the outset Each of these is correctable — but only if the claim holder knows what to look for before decisions get locked in. The Playbook walks through the moves that matter, in roughly the order we recommend thinking about them. The Trade Secret Litigation Playbook is organized into seven parts: ✔ Why Trade Secret Claims Matter Now The market forces — employee mobility, AI competition, the DTSA — that have pushed trade secrets to the center of modern competitive strategy, and the real cost of waiting once misappropriation is discovered. ✔ Trade Secret Law in Plain English A practical overview of what qualifies as a trade secret, the choice between federal DTSA and state-law venues, what misappropriation actually covers, and the full range of remedies the law makes available — written so a business reader can follow without a J.D. ✔ The Pre-Litigation Playbook What good early triage looks like in the first 72 hours, the forensic fundamentals that decide most cases, the role of the ex parte seizure order, and the trade secret identification problem that derails more well-founded cases than any other. ✔ What Your Case Is Worth The four damages theories trade secret plaintiffs can pursue, why funders evaluate cases the way private equity firms evaluate investments, and how early damages work changes counsel selection, fee structure, and settlement posture. ✔ Choosing Counsel and Structuring the Economics The three fee arrangements available to claim holders, the case for talking to a funder before hiring counsel, the specific questions to ask in a trial-counsel interview, and the side-letter terms that prevent misalignment later. ✔ Litigation Finance for Claim Holders What litigation finance is (and isn’t), why claim holders of every size now use it, the funding process step by step, the anatomy of a term sheet, and the five questions that determine whether a trade secret case is fundable. ✔ How Certum Helps Certum’s offerings across litigation funding, claim monetization, IP enforcement financing, and special situations — plus two anonymized case studies showing how these structures actually deploy in real trade secret matters. The Playbook also includes a tear-out triage sheet for the first 72 hours, a self-assessment checklist for claim holders considering funding, a business reader’s glossary, and a sources section for those who want to go deeper. This publication is designed for: Business owners and CEOs whose companies have built valuable know-how, source code, processes, or customer relationships and want to understand the asset they actually own In-house counsel and general counsel managing IP enforcement decisions, fee structures, and the increasingly common question of whether to bring litigation finance into a matter Executives at growth-stage companies weighing whether and how to pursue a suspected misappropriation without diverting operating capital from the business Litigators and law firms advising trade secret claim holders, who want a structured resource to share with sophisticated business clients The Playbook is part of Certum’s growing library of resources — including Certum’s Guide to Litigation Finance and Certum’s Model Brief Opposing Discovery of Litigation Funding — aimed at helping businesses and their counsel navigate the evolving landscape of litigation finance and risk transfer. The Trade Secret Litigation Playbook is available now. To access your copy: DOWNLOAD THE TRADE SECRET LITIGATION PLAYBOOK HERE If you are working through a live trade secret situation, a confidential conversation with Certum is free and carries no obligation. We will tell you candidly whether a case is likely to be fundable, where the evidentiary gaps are, and what the highest-leverage next moves look like — before you make decisions about counsel or strategy that are hard to undo.
By William Mara June 5, 2026
Let the Big Law AI arms race begin. Kirkland & Ellis, America’s largest and most profitable law firm, announced last week that it’s investing $500 million to build its own artificial intelligence platform. Kirkland’s bet is that proprietary AI will give it an edge over rivals stuck with off-the-shelf tools such as Harvey and Legora. Expect a handful of Kirkland’s wealthy peers to make similar bets. But for most US law firms, the AI race is a contest they won’t win because it’s a contest they’re effectively prohibited from entering. Law firms can’t raise outside capital the way other businesses do. Legal ethics rules—specifically Rule 5.4 of the Model Rules of Professional Conduct—ban firms from raising equity financing or sharing fees with non-lawyers. Those rules explain why not a single law firm, not even Kirkland & Ellis with its $10 billion in annual revenue, is publicly traded on any stock exchange. No surprise, then, that Kirkland said it would fund its AI platform from its own revenues rather than through a third-party investment. Rule 5.4 cuts law firms off from the capital markets. In nearly every other industry, robust capital markets allow small upstarts to vie with large-scale incumbents, producing healthy competition that lowers prices and improves quality. While Rule 5.4 hurts all law firms, it gives a comparative advantage to larger, wealthier law firms like Kirkland that can self-finance long-term investments. And it gives a courtroom advantage to the larger, wealthier businesses that can afford those law firms’ rates. The stakes are about nothing less than access to justice: who gets legal representation, and who is left standing outside the courthouse gates. Our civil justice system has long been plagued by an affordability and access crisis. According to New York University Law School, as many as 90% of Americans show up to state court without a lawyer. Even those individuals and small businesses who can afford a lawyer are often outmatched by better-resourced litigation opponents. The promise of “Equal Justice Under Law,” emblazoned across the façade of the US Supreme Court, is out of reach for too many. Promising market solutions have recently emerged. The capital restrictions that prevent firms from matching Kirkland’s bet are the same ones these emerging reforms are designed to dismantle. The Arizona Supreme Court in 2020 eliminated its version of Rule 5.4 allowing for alternative business structures, or ABS, where law firms can accept equity investment from non-lawyers. The court explained that the program was “rooted in the idea that entrepreneurial lawyers and nonlawyers would pilot a range of different business forms” to improve access to justice. Stanford researchers concluded in 2025 that individual consumers and small businesses are the prime beneficiaries of an ABS framework. ABS structures would allow firms to obtain third-party capital to invest in AI and other projects. A second innovation is the managed services organization, or MSO, which permits law firms to subcontract non-legal services and receive cash investments in ways that are consistent with Rule 5.4. Some firms, including McDermott Will & Emery, are exploring partnerships with MSOs to obtain third-party capital infusions they can deploy toward AI and other long-term investments. Certain MSOs, like ours at Certum Group, maintain full-stack development teams that are already building proprietary AI and other technological tools, providing smaller firms with cutting-edge capabilities that were traditionally available only to the largest firms. And then there is third-party litigation finance, where outside investors fund the fees and costs of litigation in exchange for a share of any recovery. Third-party funding enables plaintiffs and their lawyers to prosecute meritorious cases regardless of their resources. Funders also can provide non-recourse working capital to claimholders, allowing them to better compete not just in the courthouse but in the marketplace, as Suneal Bedi of Indiana University and I recently argued in the Southern California Law Review. Each of these innovations rests on the same premise: Market forces can bring third-party capital to law firms and their clients, enabling the “have nots” to obtain better results. They allow firms to invest in their clients and in themselves, equipping both to succeed in the courtroom and the market square. These innovations also share something else: sustained opposition. California, Colorado, and Illinois advancing bills to limit the ability of ABSs and MSOs to serve those states’ citizens. Third-party litigation finance has long been a target of some federal and state lawmakers. A failed provision in last year’s federal reconciliation bill would have imposed an industry-crippling excise tax of more than 40% on litigation funding returns. Critics argue that third-party investment will undermine attorney independence. This is an important concern. But as Arizona recognized when it eliminated Rule 5.4, other professional responsibility rules already preserve that independence. Legal scholarship, including work I have done with Brian Fitzpatrick of Vanderbilt Law School, suggests that third-party finance will improve rather than undermine the attorney-client relationship. The cost of legal prohibitions on third-party finance is borne by the litigant who can’t find a lawyer willing to take a meritorious case because no firm can afford the risk. It’s borne by the small business that settles a legitimate claim because it cannot match its opponent’s litigation budget. And it’s borne by the party who shows up to an eviction hearing, a custody dispute, or a debt collection action without counsel—facing an adversary who has it. Kirkland’s announcement is a preview of where the legal market is headed: A world where only the largest firms can self-finance the technology that will define competitive advantage for a generation. AI and third-party investment can close that gap and expand access to justice—but only if policymakers let them. This article was originally published on June 4, 2026, on Bloomberg Law and is available here . Copyright 2026 Bloomberg Industry Group, Inc. (800-372-1033) www.bloombergindustry.com. Reproduced with permission.